Bulletin
Investor Alert

New York Markets After Hours

June 15, 2020, 2:22 a.m. EDT

AstraZeneca to supply Europe with Covid-19 vaccine

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

By Adria Calatayud

AstraZeneca PLC said over the weekend that it has reached an agreement with Europe's Inclusive Vaccines Alliance to supply up to 400 million doses of Oxford University's Covid-19 vaccine at no profit.

Deliveries will start by the end of 2020, the British pharmaceutical giant said.

The company has recently reached similar agreements with the U.K., the U.S., the Coalition for Epidemic Preparedness Innovations, and Gavi, the Vaccine Alliance for 700 million doses, it said.

AstraZeneca said it is seeking to expand manufacturing capacity further and that it is open to collaborating with other companies in order to meet its commitment to support access to the vaccine during the pandemic.

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.